Can You Take Flonase, Singulair, and Prednisone Together?
Yes, you can safely take Flonase (fluticasone nasal spray), Singulair (montelukast), and prednisone together—there are no contraindications to concurrent use, and this combination may be clinically appropriate for severe allergic conditions or asthma exacerbations, though the necessity of all three medications simultaneously should be carefully evaluated.
Safety Profile of Concurrent Use
The combination of these three medications does not create dangerous drug interactions:
Intranasal fluticasone (Flonase) has minimal systemic absorption and does not suppress the hypothalamic-pituitary-adrenal (HPA) axis at recommended doses, even when used for 4 weeks at doses up to 800 mcg daily 1, 2.
Concurrent use of intranasal and systemic corticosteroids has been studied and found safe. Research specifically examining intranasal fluticasone combined with inhaled fluticasone showed no increased risk of HPA-axis abnormalities compared to either agent alone 3.
Montelukast (Singulair) has no known interactions with either fluticasone or prednisone that would preclude concurrent use 4.
Clinical Appropriateness and Treatment Algorithm
While safe to combine, the clinical necessity depends on your specific condition:
For Seasonal Allergic Rhinitis
Intranasal corticosteroids like Flonase are the most effective first-line treatment for moderate to severe allergic rhinitis 4.
Montelukast is less effective than intranasal corticosteroids and should not be preferred as initial therapy 4.
Oral prednisone is generally not indicated for routine allergic rhinitis management, as intranasal steroids provide superior local anti-inflammatory effects without systemic side effects 1, 2.
If you have concurrent mild persistent asthma, montelukast may provide dual benefit for both conditions, though it remains suboptimal for either condition alone 4.
For Moderate to Severe Symptoms
If symptoms are inadequately controlled on Flonase alone:
Adding an intranasal antihistamine (like azelastine) to Flonase provides clinically meaningful symptom reduction superior to either agent alone 4.
This combination is preferred over adding oral medications like montelukast 4.
When Prednisone May Be Appropriate
Short courses of oral prednisone are typically reserved for:
- Severe acute exacerbations of allergic symptoms unresponsive to topical therapy
- Concurrent asthma exacerbations requiring systemic corticosteroids
- Bridging therapy while waiting for intranasal corticosteroids to reach full effect (which takes several days)
Important Caveats and Monitoring
Systemic Corticosteroid Effects
Prednisone causes significant HPA-axis suppression even at doses as low as 7.5 mg daily after 4 weeks of use 1, 2, 5. This contrasts sharply with intranasal fluticasone, which shows no HPA suppression at therapeutic doses 1, 2.
Key monitoring considerations with prednisone include 6:
- Increased infection risk, including reactivation of latent tuberculosis, hepatitis B, strongyloides, and amebiasis
- Immunosuppression requiring avoidance of live vaccines
- Metabolic effects including hyperglycemia (requiring adjustment of antidiabetic medications)
- Ophthalmic complications including cataracts and glaucoma with prolonged use
- Drug interactions with warfarin, NSAIDs, phenytoin, and CYP3A4 substrates
Duration Considerations
Prednisone should not be stopped abruptly after prolonged use (>6 weeks) due to risk of adrenal insufficiency 6.
Intranasal fluticasone can be used long-term without the systemic concerns associated with oral corticosteroids 1, 2, 3.
Montelukast can be used chronically but remains less effective than intranasal corticosteroids for rhinitis symptoms 4.
Practical Recommendation
If you are currently taking all three medications, the combination is safe but likely represents overtreatment for isolated allergic rhinitis. Work with your prescriber to:
- Prioritize Flonase as the cornerstone of therapy for nasal symptoms 4
- Taper and discontinue prednisone as soon as clinically feasible to avoid systemic side effects 6
- Reassess the need for Singulair, as it provides minimal additional benefit when intranasal corticosteroids are optimized 4
- Consider adding intranasal antihistamine (azelastine) if symptoms remain inadequately controlled on Flonase alone 4